Kiro

Kiro is an AI startup with the slogan "Artificial intelligence serving clinical biology." The company aims to improve patient care through the use of artificial intelligence, seeking to provide understandable and relevant information to both patients and doctors. Kiro's focus is on medical biology, believing it to be central to healthcare, contributing to the diagnosis, treatment, and prevention of diseases. The startup emphasizes fostering interactions between laboratories, health professionals, and patients through the application of new technologies and artificial intelligence.

Since its inception, Kiro has closely collaborated with clinical biologists, doctors, and medical experts to develop a new approach to medical biology that is more understandable, personalized, and relevant for patients. The company is based in France and has recently secured a €13.80M Series A investment on 28 March 2023 from investors including Bpifrance, Kurma Partners, Sofinnova Partners, Propulia Capital, and business angels. Kiro's focus on leveraging AI to enhance patient care and its strong support from notable investors position it as an intriguing player in the evolving healthcare technology sector.